Weekly Varian Medical Systems, Inc. (NYSE:VAR) Ratings on Jan 14, 2019

Varian Medical Systems, Inc. (NYSE:VAR) Corporate Logo
Big Money Sentiment decreased to 0.86 in Q3 2018. It has change of 0.05, from 2018Q2’s 0.91. The ratio fall due to Varian Medical Systems, Inc. positioning: 28 sold and 176 reduced. 52 funds bought positions and 123 increased positions. Investors holded 81.61 million in 2018Q2 but now own 82.89 million shares or 1.57% more.
Ashfield Cap Limited Co has invested 0.1% of its capital in Varian Medical Systems, Inc. (NYSE:VAR). Loring Wolcott & Coolidge Fiduciary Limited Liability Partnership Ma holds 0% or 160 shs. Victory Cap Mgmt Incorporated, Ohio-based fund reported 1,359 shs. Manufacturers Life Ins The reported 0.01% stake. Profund Advsrs Limited Liability Com holds 3,952 shs. Rampart Invest Communication Limited Liability stated it has 5,483 shs or 0.05% of all its holdings. Riverhead Management Limited has invested 0.08% in Varian Medical Systems, Inc. (NYSE:VAR). 16,814 are held by Employees Retirement Association Of Colorado. Mountain Pacific Inv Advisers Id reported 90 shs. Prio Wealth Limited Partnership invested 0.07% of its capital in Varian Medical Systems, Inc. (NYSE:VAR). Daiwa Gru invested in 0.03% or 33,220 shs. Ameritas Invest Prtnrs reported 1,908 shs stake. 1,372 were reported by Tiverton Asset Ltd. Meiji Yasuda Asset Mgmt Ltd has 2,515 shs. Stratos Wealth Ptnrs Limited invested in 1,458 shs or 0.01% of the stock.

Varian Medical Systems, Inc. registered $2.73 million net activity with 0 buys and 12 sales since July 16, 2018. KUO JOHN W had sold 962 shs worth $104,707. On Wednesday, October 31 $101,603 worth of stock was sold by BISCHOPING GARY E JR. GUERTIN TIMOTHY E sold $1.11 million worth of Varian Medical Systems, Inc. (NYSE:VAR) on Wednesday, September 5.

Varian Medical Systems, Inc. (NYSE:VAR) Ratings Coverage

A total of 4 analysts rate Varian Medical Systems (NYSE:VAR) as follows: 3 “Buy”, 0 “Hold” and 1 “Sell”. Тherefore 75% are bullish. (NYSE:VAR) has 5 ratings reports on Jan 14, 2019 according to StockzIntelligence. The stock rating was upgraded by Goldman Sachs to “Buy” on Friday, January 4. On Wednesday, October 31 the stock has “Buy” rating by Citigroup. On Wednesday, January 2 the stock has “Buy” rating by Citigroup. The stock rating was maintained by JP Morgan with “Underweight” on Wednesday, October 24. Listed here are Varian Medical Systems, Inc. (NYSE:VAR) PTs and latest ratings.

04/01/2019 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Old Target: $107 New Target: $129 Upgrade
02/01/2019 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $145 New Target: $131 Maintain
28/11/2018 Broker: UBS Rating: Buy New Target: $140 Initiates Coverage On
31/10/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $127 New Target: $145 Maintain
24/10/2018 Broker: JP Morgan Old Rating: Underweight New Rating: Underweight Old Target: $110 New Target: $105 Maintain

Ticker’s shares touched $125 during the last trading session after 0.52% change.Currently Varian Medical Systems, Inc. is uptrending after 6.73% change in last January 14, 2018. VAR has also 24,007 shares volume. VAR outperformed the S&P 500 by 6.73%.

Varian Medical Systems, Inc. designs, makes, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide.The firm is valued at $11.40 billion. It operates through two divisions, Oncology Systems and Imaging Components.The P/E ratio is 77.16. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy.

For more Varian Medical Systems, Inc. (NYSE:VAR) news released briefly go to: Seekingalpha.com, Seekingalpha.com, Marketwatch.com, Seekingalpha.com or Benzinga.com. The titles are as follows: “Varian’s Halcyon OK’d in China – Seeking Alpha” released on November 28, 2018, “Varian: Dominant Moat Growth Driver – Seeking Alpha” on October 10, 2017, “Why you can’t trust Wall Street analysts – MarketWatch” with a publish date: May 11, 2018, “Accuray Running Low On Chances – Seeking Alpha” and the last “Varian Medical’s Earnings May Be ‘Cosmetically Enhanced’ (NYSE: VAR) – Benzinga” with publication date: April 11, 2017.

Varian Medical Systems, Inc. (NYSE:VAR) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.